[Budget impact analysis for peginterferon beta-1a in relapsing remitting multiple sclerosis in Italy]. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 17, n. 2S, p. 37–48, 2016. DOI: 10.7175/fe.v17i2S.1231. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1231. Acesso em: 29 oct. 2025.